Scientific deep-dive

Does PCOS Cause Weight Gain? Metabolism and Weight-Loss Evidence Review

Women with PCOS gain weight faster, but genetic studies suggest excess weight drives PCOS more than the reverse. What the evidence says about insulin resistance, metabolic rate, why weight loss can feel harder, and what actually helps.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
11 min read·17 citations

Partly — but the direction with the strongest evidence is the one most people don’t expect. Women with PCOS are about 2.8 times as likely to have obesity as women without it[1], and in a 19-year Australian study they gained about 4.6 kg more[2]. Yet genetic studies built to separate cause from effect find that a higher body weight raises the risk of developing PCOS, while a genetic tendency toward PCOS does not raise body weight[3][4]. The 2023 International PCOS Guideline sits in between: many women with PCOS do seem to gain weight more readily, but the mechanisms are unclear and there is no consistent evidence of a physiological difference[5]. Below: why, whether your metabolism is really slower, and what reliably helps.

About this article

This article explains the weight side of polycystic ovary syndrome: whether PCOS causes weight gain, which mechanisms have real evidence behind them, whether metabolic rate is lower, and what the evidence says about losing weight. We relied first on the 2023 International Evidence-based PCOS Guideline, meta-analyses, long-running population cohorts and genetic (Mendelian randomization) studies. For resting metabolic rate and appetite hormones, the only direct measurements come from smaller physiology studies, so we show where they agree and where they conflict. Treatment deep dives — GLP-1 drugs, inositol, metformin combinations — have their own articles, linked where they are relevant.

The short answer

  • PCOS and higher weight go together. Obesity is 2.77 times as common in women with PCOS[1].
  • Women with PCOS gain weight faster — 4.62 kg more over 19 years in an Australian cohort[2].
  • The clearest causal arrow points from weight to PCOS, not the reverse, in two genetic studies[3][4].
  • Metabolic rate is mostly not meaningfully lower. Studies conflict, and the largest found the same absolute calorie burn at rest[13][15].
  • Weight loss works about as well, and modest loss counts. Lifestyle programs appear equally effective in PCOS[5]; losing more than 5% has been tied to better cycles[16].

How strongly PCOS and weight are linked

PCOS affects roughly 10% to 13% of reproductive-age women worldwide[5]. The best pooled estimate of how often it comes with excess weight is a systematic review and meta-analysis of 35 studies covering 15,129 women. Compared with women without PCOS, women with PCOS had a higher prevalence of overweight (risk ratio 1.95), obesity (2.77) and central obesity (1.73)[1]. The gap varied by ethnicity — the increase in obesity was larger among Caucasian women with PCOS than among Asian women with PCOS — and the authors flagged substantial differences between studies[1].

Magnitude comparison

How much more common excess weight is in women with PCOS than in women without it — pooled risk ratios from a meta-analysis of 35 studies (15,129 women). A value of 1.0 would mean no difference.[1]

  • Obesity2.77 × as common
  • Overweight1.95 × as common
  • Central (abdominal) obesity1.73 × as common
How much more common excess weight is in women with PCOS than in women without it — pooled risk ratios from a meta-analysis of 35 studies (15,129 women). A value of 1.0 would mean no difference.

That also means PCOS is not a weight diagnosis. Many women with PCOS are at a lower weight, and the guideline makes separate recommendations for them[5]. The question is what sits behind the higher average.

Women with PCOS do gain weight faster

The strongest long-term data come from the Australian Longitudinal Study on Women’s Health, which followed women born in 1973–1978 through seven surveys over 19 years (14,127 women at the first survey). After adjustment, women with PCOS gained 0.26 kg more per year than women without PCOS — 4.62 kg more over the 19 years[2]. Energy intake, sitting time and activity all mattered, and the authors concluded that lifestyle has a “more profound impact” on weight gain in women with PCOS than in women without it[2]. Diet and activity were self-reported, the study’s main weakness.

A Finnish birth cohort adds timing. The Northern Finland Birth Cohort 1966 measured 5,889 women at ages 14, 31 and 46. Women with PCOS symptoms or a PCOS diagnosis had the highest BMI at every age, and their BMI climbed faster than that of women without PCOS symptoms between ages 14 and 31 — but not between 31 and 46[6]. The authors suggest early adulthood may be a sensitive window, when weight gain plays a crucial role in PCOS emerging[6].

Chicken or egg? What genetic studies add

Cohorts show that PCOS and weight gain travel together, but not which one is doing the pushing. Mendelian randomization studies try to answer that by treating the gene variants people are born with as a natural experiment. If the variants that raise BMI also raise PCOS risk, higher BMI is likely a cause of PCOS. If PCOS-risk variants raise BMI, the arrow runs the other way.

Two studies tested both directions and landed in the same place. In 750 women of European ancestry with PCOS and 1,567 BMI-matched controls, each standard deviation of genetically higher BMI came with 4.89 times higher odds of PCOS, while genetic risk of PCOS did not influence BMI[3]. A larger East Asian analysis — 4,386 PCOS cases and 8,017 controls, with BMI genetics from up to 173,430 people — found the same pattern: higher BMI raised the odds of PCOS (odds ratio 2.21 per standard deviation), and PCOS genetic risk had no significant effect on BMI[4].

That does not prove PCOS has no effect on weight — these studies test inherited tendencies, and the cohorts do show faster gain. But the popular story that PCOS “makes” you gain weight is less certain than the reverse, and a Cochrane review notes that obesity worsens how PCOS presents[7]. The guideline captures the uncertainty: there is “a lack of consistent evidence of physiological or behavioural lifestyle differences, related to weight,” yet many women with PCOS “will have underlying mechanisms that drive greater longitudinal weight gain and higher BMI,” even though “the specific mechanisms are unclear”[5]. The fairest reading: weight-to-PCOS is well supported; PCOS-to-weight is plausible but unexplained.

The mechanisms that have evidence behind them

Insulin resistance: real, and worse with extra weight

Insulin resistance is the best-documented metabolic feature of PCOS. A meta-analysis of 28 studies using the gold-standard clamp test found insulin sensitivity was 27% lower in women with PCOS than in controls, a reduction that was independent of BMI. Higher BMI then worsened insulin sensitivity by a further 15% in women with PCOS compared with controls[8]. PCOS carries built-in insulin resistance, and extra weight hits harder. What research has not shown is how much insulin resistance causes weight gain rather than resulting from it. The guideline also advises against routine insulin blood tests, because available assays are of limited clinical relevance[5].

Androgens and belly fat: a plausible loop

Central obesity is more common in PCOS[1]. A long-standing hypothesis holds that abdominal fat, and the insulin resistance it brings, pushes the ovaries to make more androgens — while androgen excess may in turn favor abdominal fat storage, creating a “vicious circle”[9]. There are supporting pieces: in the Finnish cohort, a higher free androgen index was independently associated with PCOS[6], and lower sex hormone-binding globulin (SHBG), which leaves more testosterone active, tracked with lower insulin sensitivity regardless of BMI[8]. But this rests on associations and a narrative review; androgens have not been shown to be a major cause of weight gain.

Appetite: mixed signals

The appetite data are small and inconsistent. In a diet study of 20 overweight women with PCOS and 12 without, those with PCOS felt less full and hungrier after a test meal and had lower fasting ghrelin, a hunger hormone[10]. A later study from the same group, matching 14 women with PCOS to 14 without found lower ghrelin again, but no differences in reported appetite, other gut hormones or how much they ate at a buffet — the authors concluded it is not clear whether appetite regulation is impaired[11]. Across 78 energy-balance studies, 57% found no difference between women with and without PCOS and 43% found altered responses[12].

Is your metabolism slower with PCOS?

This is where the claim you will hear most often — “PCOS slows your metabolism” — runs furthest ahead of the data. Resting energy expenditure, the calories you burn at rest, has been measured in women with PCOS many times, and the results genuinely conflict.

Resting energy expenditure in women with and without PCOS
StudyWho was measuredResult
Tosi 2024[13]266 women with PCOS, 51 controls; indirect calorimetryAbsolute resting energy expenditure similar. Lower in PCOS only per kg of fat-free mass (31.8 vs 35.4 kcal/kg/day), in every weight group and phenotype
Georgopoulos 2009[14]91 women with PCOS and high androgens, 48 controls; indirect calorimetryAdjusted basal metabolic rate lower in PCOS, lowest in women with insulin resistance
Larsson 2016[15]72 women with PCOS, 30 controls; indirect calorimetryNo difference after adjusting for age and BMI (1,411 vs 1,325 kcal/day)

How to read that: in the largest study, women with PCOS burned the same calories at rest in absolute terms; the gap appeared only after dividing by fat-free mass, the design was cross-sectional, and lifestyle was not captured[13]. The lower ratio also showed up in normal-weight women with PCOS, which the authors say means other factors must play a role in weight gain[13]. The Greek study reported a clearly lower rate[14] and the Swedish study none[15], so taken together the measurements point to a small gap at most. A scoping review calls the evidence for altered energy balance “inconsistent, yet preliminary”[12].

The practical upshot: most measurements do not show a large, consistent deficit, so there is no strong reason to assume your calorie needs are far below standard estimates. The Swedish authors concluded that women with PCOS “should have equal abilities in terms of energy metabolism to lose weight”[15].

Is it harder to lose weight with PCOS?

On the narrow question — do women with PCOS lose less weight on the same plan? — the direct evidence is reassuring. When matched women with and without PCOS followed the same 8-week energy-restricted diet, weight loss (4.2 kg on average) did not differ significantly between the groups[11]. The guideline’s position is that healthy lifestyle and weight management, delivered with structured, intensive and ongoing support, “appears equally effective in PCOS as in the general population”[5].

Why it can still feel harder: the background drift toward weight gain is faster in PCOS[2], lifestyle factors appear to move weight more in PCOS[2], and extra weight costs women with PCOS more insulin sensitivity[8]. The guideline acknowledges these underlying mechanisms may “underpin greater challenges with weight management”[5]. There is a psychological load too: women with PCOS scored higher on weight and dieting concern[15], and the guideline asks clinicians to recognize the harms of the weight stigma many experience[5].

What works for weight with PCOS

Lifestyle: no special PCOS diet required

The guideline recommends healthy eating and/or physical activity for all women with PCOS, noting benefits “even in the absence of weight loss”[5]. It found no evidence that any one diet composition, or any one type or intensity of exercise, beats another[5]. It points to 150–300 minutes a week of moderate activity to prevent weight gain, and at least 250 minutes for modest weight loss and preventing regain, plus muscle strengthening twice a week; where weight loss is the goal, a tailored energy deficit[5].

Against minimal treatment, lifestyle programs cut weight by about 1.7 kg and the free androgen index by 1.11 in a Cochrane review of 15 trials — modest numbers from mostly short, low-quality studies[7].

How much weight loss makes a difference

You do not need to reach a “normal” BMI to see changes. In an early study of 24 women with PCOS and obesity on a low-calorie diet for six to seven months, the 13 who lost more than 5% of their weight saw free testosterone and fasting insulin fall; 9 of the 11 with menstrual problems improved (five conceived) and hirsutism decreased in 40%. Among those who lost less, only one of eight with menstrual problems improved[16]. The study was small and uncontrolled, so treat 5% as a marker, not a precise threshold. The guideline likewise says weight management can bring significant clinical improvements, and that better waist size and metabolic health have value in their own right[5]. For how cycles can change as weight comes off, see our article on weight loss, hormones and the menstrual cycle.

Metformin: modest help, mainly metabolic

Metformin’s weight effect is modest. A meta-analysis done for the 2023 guideline found that, compared with placebo, metformin lowered BMI by 0.53 kg/m² — roughly 1.4 kg (about 3 lb) for a woman 5 ft 5 in tall — and improved insulin resistance and fasting glucose, with more mild gastrointestinal side effects[17]. The guideline says metformin should be considered in adults with PCOS and a BMI of 25 or higher, that women should be told metformin and active lifestyle change have similar efficacy, and that metformin is more effective than inositol, which offers limited clinical benefit in PCOS[5]. Our inositol evidence review goes through that comparison, and our GLP-1, spironolactone and metformin combination guide covers how the medicines are used together.

Where GLP-1 medications fit

For women at higher weight, the guideline says anti-obesity medications — including the GLP-1 receptor agonists liraglutide and semaglutide, and orlistat — could be considered alongside active lifestyle change, following general population guidelines[5]. It also asks clinicians to ensure effective contraception when pregnancy is possible, because pregnancy safety data are lacking, and to discuss the potential need for long-term use given the high risk of weight regain after stopping[5]. We cover the PCOS trial data in GLP-1s for PCOS and semaglutide specifically in Ozempic and PCOS.

What this means if you have PCOS

If you have PCOS and have gained weight, the evidence supports neither blaming yourself nor assuming your body cannot lose weight. Three points matter most in practice:

  • Preventing further gain is the highest-yield target. The biggest divergence in weight shows up between the teens and early thirties[6], and the guideline puts a lifelong focus on preventing further gain at the center of care[5]. Holding steady is a real result, not a failure.
  • Aim for around 5%, not a “normal” BMI. Modest loss is where symptom improvements have been seen[16], and improvements in waist size and metabolic health count on their own[5].
  • Pick the plan you can keep. No diet or exercise type has proven superior in PCOS[5], so consistency and support matter more than the label. If lifestyle change alone is not moving things, useful questions for a clinician are whether metformin fits your metabolic profile and whether you meet the general criteria for an anti-obesity medication.

Frequently Asked Questions

Both directions may be involved, but the evidence is stronger for weight driving PCOS. Genetic (Mendelian randomization) studies find that a higher BMI raises the risk of PCOS, while a genetic tendency toward PCOS does not raise BMI. At the same time, women with PCOS gained about 4.6 kg more than women without PCOS over 19 years in a large Australian cohort, so PCOS may also make weight gain more likely through mechanisms that are not yet understood.
Probably not by much. Studies measuring resting energy expenditure conflict. The largest calorimetry study found women with PCOS burned about the same calories at rest in absolute terms, with a lower value only after adjusting for fat-free mass. Another found no difference after accounting for age and BMI, and a third found a lower rate, so any average gap appears small.
Modest amounts can help. In an early study, women with PCOS who lost more than 5% of their starting weight had lower free testosterone and insulin, and most of those with menstrual problems improved. The study was small, so 5% is a useful marker rather than a strict threshold. The 2023 International PCOS Guideline also notes that improvements in waist size and metabolic health have value in their own right.
No. The 2023 International PCOS Guideline found no evidence that any one diet composition works better than another for weight, metabolic, hormonal or reproductive outcomes in PCOS. It recommends any healthy eating pattern consistent with population guidelines, tailored to your preferences and goals, alongside regular physical activity. The best plan is the one you can sustain.

References

  1. 1.Lim SS, Davies MJ, Norman RJ, Moran LJ. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012. PMID: 22767467.
  2. 2.Awoke MA, Earnest A, Joham AE, Hodge AM, Teede HJ, Brown WJ, Moran LJ. Weight gain and lifestyle factors in women with and without polycystic ovary syndrome. Hum Reprod. 2021. PMID: 34788426.
  3. 3.Brower MA, Hai Y, Jones MR, Guo X, Chen YI, Rotter JI, Krauss RM, Legro RS, Azziz R, Goodarzi MO. Bidirectional Mendelian randomization to explore the causal relationships between body mass index and polycystic ovary syndrome. Hum Reprod. 2019. PMID: 30496407.
  4. 4.Zhao Y, Xu Y, Wang X, Xu L, Chen J, Gao C, et al. Body Mass Index and Polycystic Ovary Syndrome: A 2-Sample Bidirectional Mendelian Randomization Study. J Clin Endocrinol Metab. 2020. PMID: 32163573.
  5. 5.Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023. PMID: 37580314.
  6. 6.Ollila MM, Piltonen T, Puukka K, Ruokonen A, Järvelin MR, Tapanainen JS, Franks S, Morin-Papunen L. Weight Gain and Dyslipidemia in Early Adulthood Associate With Polycystic Ovary Syndrome: Prospective Cohort Study. J Clin Endocrinol Metab. 2016. PMID: 26652764.
  7. 7.Lim SS, Hutchison SK, Van Ryswyk E, Norman RJ, Teede HJ, Moran LJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2019. PMID: 30921477.
  8. 8.Cassar S, Misso ML, Hopkins WG, Shaw CS, Teede HJ, Stepto NK. Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies. Hum Reprod. 2016. PMID: 27907900.
  9. 9.Escobar-Morreale HF, San Millán JL. Abdominal adiposity and the polycystic ovary syndrome. Trends Endocrinol Metab. 2007. PMID: 17693095.
  10. 10.Moran LJ, Noakes M, Clifton PM, Wittert GA, Tomlinson L, Galletly C, Luscombe ND, Norman RJ. Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition. J Clin Endocrinol Metab. 2004. PMID: 15240612.
  11. 11.Moran LJ, Noakes M, Clifton PM, Wittert GA, Le Roux CW, Ghatei MA, Bloom SR, Norman RJ. Postprandial ghrelin, cholecystokinin, peptide YY, and appetite before and after weight loss in overweight women with and without polycystic ovary syndrome. Am J Clin Nutr. 2007. PMID: 18065576.
  12. 12.Nguo K, McGowan M, Cowan S, Davidson Z, Pirotta S, Dordevic AL, et al. Exploring the physiological factors relating to energy balance in women with polycystic ovary syndrome: a scoping review. Nutr Rev. 2025. PMID: 38345350.
  13. 13.Tosi F, Rosmini F, Gremes V, Lucarini F, Zandonà M, Zanolin ME, et al. Resting energy expenditure in women with polycystic ovary syndrome. Hum Reprod. 2024. PMID: 38867472.
  14. 14.Georgopoulos NA, Saltamavros AD, Vervita V, Karkoulias K, Adonakis G, Decavalas G, et al. Basal metabolic rate is decreased in women with polycystic ovary syndrome and biochemical hyperandrogenemia and is associated with insulin resistance. Fertil Steril. 2009. PMID: 18678372.
  15. 15.Larsson I, Hulthén L, Landén M, Pålsson E, Janson P, Stener-Victorin E. Dietary intake, resting energy expenditure, and eating behavior in women with and without polycystic ovary syndrome. Clin Nutr. 2016. PMID: 25743212.
  16. 16.Kiddy DS, Hamilton-Fairley D, Bush A, Short F, Anyaoku V, Reed MJ, Franks S. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 1992. PMID: 1559293.
  17. 17.Melin J, Forslund M, Alesi S, Piltonen T, Romualdi D, Spritzer PM, et al. The impact of metformin with or without lifestyle modification versus placebo on polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Eur J Endocrinol. 2023. PMID: 37536294.

GLP-1 + Spironolactone + Metformin for PCOS: The Stacking Protocol

PCOS patients often stack a GLP-1, spironolactone for androgens, and metformin for insulin resistance. We review the Jensterle 2015 + Carmina 2023 + Salamun fertility data, the potassium monitoring, and the practical PCOS combination protocol.

12 min read

Does Anxiety Cause Weight Loss? Evidence Review (Mechanism, GI Symptoms, Sleep)

Anxiety CAN cause weight loss via appetite suppression + GI symptoms + increased BMR. Also can cause weight gain via stress-eating + cortisol. Mechanism + clinician guidance.

14 min read

Tirzepatide vs Retatrutide: GIP/GLP-1 vs Triple Agonist Evidence

Tirzepatide hits GLP-1 + GIP. Retatrutide adds glucagon for additional energy expenditure. We walk through the mechanism math, SURMOUNT-1 vs phase 2 retatrutide head-to-head magnitude, and the trade-offs in HR + nausea + weight loss.

11 min read

Ozempic and PCOS: What the Evidence Says About Semaglutide for Polycystic Ovary Syndrome (2026)

Is Ozempic (semaglutide) approved for PCOS? No — it's off-label. What the emerging evidence shows on weight, insulin resistance, menstrual regularity, and ovulation, plus metformin comparison and the 2-month pre-pregnancy washout. An off-label, clinician-led decision.

11 min read

Do GLP-1 Drugs Speed Up or Slow Your Metabolism?

Does Ozempic boost or slow your metabolism? The evidence: GLP-1 weight loss is driven by eating less, not burning more. Resting energy expenditure doesn't rise — it falls with weight loss (metabolic adaptation), and the brown-fat theory is unproven in humans.

10 min read

GLP-1 and Metabolic Rate: Energy Expenditure & Brown Fat (2026)

Do GLP-1 drugs raise metabolic rate or activate brown fat? In humans, weight loss comes from eating less, not burning more. The brown-fat story is mostly rodents.

11 min read

Where to get GLP-1 safely: vetted online providers

Vetted telehealth providers that prescribe online. We compare pricing, form, and states served.

No insurance needed · vetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

8.1

RxSpan MD

Physician-led, pharmacy-transparent compounded GLP-1 with brand-name options

8.0

Strut Health

Oral-lozenge compounded GLP-1 access

7.8

Yucca Health

Mainstream telehealth GLP-1 access